Vétoquinol SA engages in designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific regions. It is a player in the animal health sector serving both the livestock such as cattle and pigs and pet dogs and cats markets. The company operates through the following segments: Europe, Americas, and Asia Pacific and Rest of the World. It manufactures products for cattle, swine, and pets. It also manufactures antibiotic, anti-inflammatory, cardiology, and nephrology drugs. Vétoquinol was founded by Joseph Frechin in 1933 and is headquartered in Lure, France.